Daniel W. Lin, MD, reviews new guidance on using MRI, biomarkers, and more, to improve the detection of prostate cancer.

A new UCL-led international trial will assess whether AI can perform as well as expert radiologists at detecting prostate cancer on MRI scans. Following the practice-changing UCL-led PROMIS and ...

A large analysis suggests that a multivariable risk assessment tool, called Stockholm3, can detect substantially more ...

Phase 3 data suggest PSMA-PET-CT could reduce unnecessary prostate biopsies in selected high-risk men, though longer ...

Patients with advanced prostate cancer may need periodic imaging scans to catch tumor growth even with stable levels of ...

(HealthDay News) — Stockholm3, which combines prostate-specific antigen (PSA), plasma protein biomarkers, polygenic risk, and clinical factors offers greater clinical net benefit for detecting ...

For many women caring for a husband, partner, father or loved one with advanced prostate cancer, there comes a moment when the conversation suddenly becomes much more technical. The oncologist starts ...

Thousands of men in England who have prostate cancer will be offered high-powered precision radiotherapy that will slash the number of treatment sessions they typically need from 20 to just five.

For many men, a prostate cancer scare starts with one number. A PSA result comes back high, and ...